Newsroom
March 24, 2011
SAN ANTONIO (March 24, 2011) – Rong Li, Ph.D., a professor of molecular medicine at The University of Texas Health Science Center at San Antonio, was awarded $741,446 by the Cancer Prevention and Research Institute of Texas for his work in understanding how the dense tissue in breast tumors contributes to estrogen production and tumor […]
March 23, 2011
Leading researchers and caregivers will present the latest information in cancer-fighting drugs in a case-based format, expanded to include nursing sessions, the newest FDA-approved drugs and promising investigator-initiated studies on novel drug mechanisms.
March 22, 2011
A new study launching today at The University of Texas Health Science Center at San Antonio proposes a revolutionary new way to evaluate men who are having PSA testing for prostate cancer.
March 18, 2011
Andrew P. Hinck, Ph.D., spends his days methodically mapping a tiny universe inhabited by an important protein in the human body – an effort that could have an enormous impact on cancer treatment.
March 11, 2011
For the individual patient, clinical trials are a chance to try cutting-edge cancer therapies under close and caring supervision. For the world, clinical trials have the potential to develop new weapons in the fight against cancer.
February 24, 2011
Over-reliance on test could result in unnecessary biopsies